Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN3348 vs Mitomycin C in BCG Recurrent/Refractory NMIBC
NCT01200992Phase 3Terminated
- Sponsor
- Bioniche Life Sciences
- Start
- Nov 2010
- Primary completion
- Apr 2013
- Modality
- Biologic, CWE (Cell wall extract)
- Countries
- 6
01
Overview
A Phase 3 trial of mycobacterial cell wall-DNA complex in Non-muscle-invasive bladder cancer (NMIBC), sponsored by Bioniche Life Sciences. Started Nov 2010; status: terminated.
02
Drugs
mycobacterial cell wall-DNA complex
03
Conditions
Non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT01200992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200992.